{"transactions":[{"id":2329636,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129033,"kind":"person","name":"Sial Jay","position":1,"cik":"0001873057","reported_name":"Sial Jay","relationship":{"officer":true,"officer_title":"Chief Administration Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-18T01:00:24.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":117200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 substantially equal monthly installments from the grant date."}],"balance_after":117200,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":117200},"source":{"system":"sec-edgar","filing":"0001140361-22-009981","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009981/form4.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2334478,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129033,"kind":"person","name":"Sial Jay","position":1,"cik":"0001873057","reported_name":"Sial Jay","relationship":{"officer":true,"officer_title":"Chief Administration Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-16T01:34:21.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":117200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":117200,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":117200},"source":{"system":"sec-edgar","filing":"0001140361-22-009661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009661/form4.xml","form_type":"4"}},{"id":2631436,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129033,"kind":"person","name":"Sial Jay","position":1,"cik":"0001873057","reported_name":"Sial Jay","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2021-07-20T01:30:35.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU Grant vests and becomes exercisable in four equal installments on July 15 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Mr. Sial's Executive Employment Agreement, dated as of July 6, 2021 and effective July 15, 2021), subject to continued service through each vesting date."}],"balance_after":35700,"derivative":{"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":35700},"source":{"system":"sec-edgar","filing":"0001140361-21-024855","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121024855/form4.xml","form_type":"4"}},{"id":2631435,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129033,"kind":"person","name":"Sial Jay","position":1,"cik":"0001873057","reported_name":"Sial Jay","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2021-07-20T01:30:35.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on July 15, 2022, and 1/36 of the remaining shares covered thereby vesting on the 15th day of each calendar month from August 2022 through July 15, 2025, subject to continued service through each vesting date."}],"balance_after":71000,"derivative":{"exercise_price":10.31,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001140361-21-024855","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121024855/form4.xml","form_type":"4"}}]}